Open Access
| Numéro |
Med Sci (Paris)
Volume 38, Numéro 10, Octobre 2022
|
|
|---|---|---|
| Page(s) | 772 - 775 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2022121 | |
| Publié en ligne | 11 octobre 2022 | |
- Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5 161 patients. Lancet Oncol 2022; 23 : 149–60. [CrossRef] [PubMed] [Google Scholar]
- Kuett L, Catena R, Ozcan A, et al. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment. Nat Cancer 2022; 3 : 122–33. [CrossRef] [PubMed] [Google Scholar]
- Ali HR, Dariush A, Provenzano E, et al. Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res 2016 ; 18 : 21. [CrossRef] [PubMed] [Google Scholar]
- Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 ; 313 : 1960–1964. [Google Scholar]
- Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003 ; 348 : 203–213. [CrossRef] [PubMed] [Google Scholar]
- Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009 ; 9 : 353–363. [CrossRef] [PubMed] [Google Scholar]
- Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008 ; 26 : 4410–4417. [CrossRef] [PubMed] [Google Scholar]
- Binnewies M, Pollack JL, Rudolph J, et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep 2021; 37 : 109844. [CrossRef] [PubMed] [Google Scholar]
- Huang TX, Tan XY, Huang HS, et al. Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity. Gut 2022; 71 : 333–44. [CrossRef] [PubMed] [Google Scholar]
- Bassez A, Vos H, Van Dyck L, et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med 2021; 27 : 820–32. [CrossRef] [PubMed] [Google Scholar]
- Nagasaki J, Inozume T, Sax N, et al. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes. Cell Rep 2022; 38 : 110331. [CrossRef] [PubMed] [Google Scholar]
- Liu B, Hu X, Feng K, et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer 2022; 3 : 108–21. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.